Paper39733268
PHOTOBIOMODULATION THERAPY FOR SEROUS PIGMENT EPITHELIUM DETACHMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Iovino C and 5 others. Retin Cases Brief Rep, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. PHOTOBIOMODULATION THERAPY FOR SEROUS PIGMENT EPITHELIUM DETACHMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Papers, record 39733268. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39733268
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PHOTOBIOMODULATION THERAPY FOR SEROUS PIGMENT EPITHELIUM DETACHMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Serous Chorioretinopathy | Major topic |
| Retinal Detachment | Major topic |
| Retinal Pigment Epithelium | Major topic |
| Low-Level Light Therapy | Major topic |
| Humans | |
| Male | |
| Middle Aged | |
| Visual Acuity | |
| Chronic Disease | |
| Tomography, Optical Coherence | |
| Fluorescein Angiography | |
| Fundus Oculi |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37027819 | PHOTOBIOMODULATION THERAPY FOR LARGE SOFT DRUSEN AND DRUSENOID PIGMENT EPITHELIAL DETACHMENT IN AGE-RELATED MACULAR DEGENERATION: A Single-Center Prospective Pilot Study. | Retina | 2023 | https://conductscience.org/library/papers/37027819 | PubMed |
| 2 | 27084564 | Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging. | Ophthalmology | 2016 | https://conductscience.org/library/papers/27084564 | PubMed |
| 3 | 36933125 | Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature. | Ophthalmol Ther | 2023 | https://conductscience.org/library/papers/36933125 | PubMed |
| 4 | 37890879 | Outcomes of low-level light therapy before and after cataract surgery for the prophylaxis of postoperative dry eye: a prospective randomised double-masked controlled clinical trial. | Br J Ophthalmol | 2024 | https://conductscience.org/library/papers/37890879 | PubMed |
| 5 | 37972955 | LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System. | Retina | 2024 | https://conductscience.org/library/papers/37972955 | PubMed |
| 6 | 31404033 | A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION. | Retina | 2020 | https://conductscience.org/library/papers/31404033 | PubMed |
| 7 | 31267093 | Retinal pigment epithelium apertures as a late complication of longstanding serous pigment epithelium detachments in chronic central serous chorioretinopathy. | Eye (Lond) | 2019 | https://conductscience.org/library/papers/31267093 | PubMed |
| 8 | 31319157 | Central serous chorioretinopathy: Towards an evidence-based treatment guideline. | Prog Retin Eye Res | 2019 | https://conductscience.org/library/papers/31319157 | PubMed |
| 9 | 30002072 | Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. | Br J Ophthalmol | 2019 | https://conductscience.org/library/papers/30002072 | PubMed |
| 10 | 37768527 | Shedding Light on Photobiomodulation Therapy for Age-Related Macular Degeneration: A Narrative Review. | Ophthalmol Ther | 2023 | https://conductscience.org/library/papers/37768527 | PubMed |
| 11 | 36582033 | Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results From a Prospective Randomized Comparative Study. | Cornea | 2023 | https://conductscience.org/library/papers/36582033 | PubMed |
| 12 | 22788735 | Central serous chorioretinopathy: a review of epidemiology and pathophysiology. | Clin Exp Ophthalmol | 2013 | https://conductscience.org/library/papers/22788735 | PubMed |
| 13 | 35742861 | Effect of Photobiomodulation in Suppression of Oxidative Stress on Retinal Pigment Epithelium. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35742861 | PubMed |
| 14 | 32503238 | Photobiomodulation-Underlying Mechanism and Clinical Applications. | J Clin Med | 2020 | https://conductscience.org/library/papers/32503238 | PubMed |
| 15 | 1741142 | Central serous chorioretinopathy occurring in patients 60 years of age and older. | Ophthalmology | 1992 | https://conductscience.org/library/papers/1741142 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42449957 | Molecular Mechanisms of Photobiomodulation in Retinal Diseases: Cytochrome c Oxidase, Mitochondrial Bioenergetics and Cytoprotective Signalling. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42449957 | PubMed |
| 41198996 | Photobiomodulation Therapy with Low-Level Light in Chronic Central Serous Chorioretinopathy: A Pilot Study. | Ophthalmol Ther | 2026 | https://conductscience.org/library/papers/41198996 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39733268
GET https://conductscience.org/api/papers/v1/39733268/authors